Approach Could Limit Toxicity of CAR T Therapy in Acute Myeloid Leukemia

12:51 EDT 31 May 2018 | Drug Discovery Development

News
New study uses CRISPR/Cas9 to make CD33 CAR T Cells cancer-specific.
Contributed Author: 
University of Pennsylvania School of Medicine
Topics: 

Original Article: Approach Could Limit Toxicity of CAR T Therapy in Acute Myeloid Leukemia

More From BioPortfolio on "Approach Could Limit Toxicity of CAR T Therapy in Acute Myeloid Leukemia"